What telehealth programs charge for KPV
One KPV price, at one US program. Price checked Nov 21, 2026.
Cheapest KPV this week
HealthRX$199 a month, month-to-month. The 12-month plan is $99 the first month, then $129 a monthKPV injectionChecked November 21, 2026 on HealthRX's own pageCheck price at HealthRX →
Prices checked by The Pep Chart on , from each program's own page. How we check prices | How we make money
KPV price comparison chart
- Membership included
- Full refund if not prescribed
DetailsHide details
- Membership included
- Full refund if not prescribed
- Care team messaging
After the click: HealthRX's site, then a plan pick and intake
We read healthrx.com on November 21, 2026.
The FDA lists KPV among bulk drug substances that were in Category 2, its list of substances that may present significant safety risks, and whose nominations were then withdrawn.
Prices checked by The Pep Chart on , from each program's own page. How we check prices | How we make money
Programs pay us when you sign up through our links. Affiliate disclosure
Is KPV legal? The FDA lists KPV among bulk drug substances that were in Category 2, its list of substances that may present significant safety risks, and whose nominations were then withdrawn. The FDA says it has found no human exposure data on KPV by any route. KPV is not named on the FDA's 503A category lists. An HHS policy dated October 28, 2026 covers KPV acetate in topical and oral forms only, under conditions, for 503A compounding. That is not FDA approval. FDA status, with sources and where to buy peptides legally.
Questions
How much does KPV cost through a US telehealth program?
HealthRX prints $199 a month: month-to-month. The 12-month plan is $99 the first month, then $129 a month. Read November 21, 2026 from HealthRX's own page.
When were these prices checked?
Each row carries the date its price was read. The oldest on this page is November 21, 2026. We read every price again each week and save a copy of the page.
Is KPV legal?
The FDA lists KPV among bulk drug substances that were in Category 2, its list of substances that may present significant safety risks, and whose nominations were then withdrawn. The FDA says it has found no human exposure data on KPV by any route. KPV is not named on the FDA's 503A category lists. An HHS policy dated October 28, 2026 covers KPV acetate in topical and oral forms only, under conditions, for 503A compounding. That is not FDA approval. A program needs a prescription from a US clinician before a pharmacy fills it.
Sources
- HealthRX, KPV injection price page, read November 21, 2026
- How we check prices
Compare prices by peptide
Not medical advice.
FDA status
The FDA lists KPV among bulk drug substances that were in Category 2, its list of substances that may present significant safety risks, and whose nominations were then withdrawn.